See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261734_2017_Aeolus_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001261734, Aeolus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,135,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 32,000 |
| 4 | LiabilitiesCurrent | 972,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,442,973 |
| 9 | ResearchAndDevelopmentExpense | 3,026,895 |
| 10 | remainder_Expenses | 331,522 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,344,686 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,167,000 |
| 1 | Liabilities | 972,000 |
| 2 | Expenses | 5,801,390 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,195,000 |
| 5 | NetIncome | -3,456,704 |
| 6 | ComprehensiveNetIncome | -3,456,704 |
| 7 | BaseVar | 6,642,538 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 2.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
